The Discounted Cash Flow (DCF) valuation of Bridge Biotherapeutics Inc (288330.KQ) is (12,467.47) KRW. With the latest stock price at 731.00 KRW, the upside of Bridge Biotherapeutics Inc based on DCF is -1805.5%.
Based on the latest price of 731.00 KRW and our DCF valuation, Bridge Biotherapeutics Inc (288330.KQ) is a sell. selling 288330.KQ stocks now will result in a potential gain of 1805.5%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.1% - 7.3% | 6.2% |
| Long-term Growth Rate | 3.0% - 4.8% | 3.9% |
| Fair Price | (109,428.46) - (6,833.17) | (12,467.47) |
| Upside | -15069.7% - -1034.8% | -1805.5% |